Literature DB >> 6785238

Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.

M M Hayes, F Kierszenbaum.   

Abstract

The responses of spleen cells from mice infected with Trypanosoma cruzi to stimulation with T (concanavalin A and phytohemagglutinin) or B (lipopolysaccharide) cell-specific mitogens were monitored during the acute, transition, and chronic states of the disease. A marked reduction in the responses of infected mouse cells with respect to those of uninfected animals was observed during the acute stage, regardless of whether or not the infective dose was lethal. Reduced or absent responses were recorded with suboptimal, optimal, and supraoptimal concentrations of the mitogens. Normal levels of responsiveness to concanavalin A, phytohemagglutinin, and lipopolysaccharide were observed during the chronic stage of the disease. The trend of return to normal responses was initiated around day 40 after infection with 25 parasites. At this time, a marked decline in parasitemia levels, cessation of mortality, and disappearance of visible signs of disease began to be observed defining the transition stage that precedes establishment of chronicity. T cell levels of the spleen were markedly reduced during the acute period and returned during the chronic phase. Instead, absolute levels of B cells were significantly increased during the acute period but also normalize in the chronic phase. Immunosuppression of chronically infected mice with cyclophosphamide led to a temporary return to acute infection-type conditions, even in animals with undetectable levels of parasitemia before treatment. These results suggest that reduced T cell responses during acute experimental Chagas' disease might in part to be due to depletion of the T cell compartment. Decreased B cell responses in the presence of significant numbers of B lymphocytes implies a suppressive phenomenon, B cell alteration, or a combination of both possibilities. Recrudescence of the disease after immunosuppression with cyclophosphamide suggests that immunological mechanisms play an important role, not only in the gain of control over T. cruzi infected by the host but also in the maintenance of the chronic status.

Entities:  

Mesh:

Year:  1981        PMID: 6785238      PMCID: PMC351433          DOI: 10.1128/iai.31.3.1117-1124.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Suppression of cellular responses in mice during Trypanosoma cruzi infections.

Authors:  E C Rowland; R E Kuhn
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Cytotoxic effects of normal sera on lymphoid cells. III. Selective killing of mouse T cells by normal guinea pig serum.

Authors:  D B Budzko; F Kierszenbaum; B H Waksman
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.

Authors:  F Kierszenbaum; J G Howard
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

4.  [Chronic infection of mice with Trypanosome cruzi. Experimental model of Chagas disease].

Authors:  R P Laguens; P Cabeza Meckert; M A Basombrío; G J Chambó; P M Cossio; R M Arana; R Gelpi
Journal:  Medicina (B Aires)       Date:  1980       Impact factor: 0.653

5.  Cellular immunity in chronic Chagas' disease.

Authors:  O M Montufar; C C Musatti; E Mendes; N F Mendes
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

6.  Trypanosoma cruzi: immunosuppressed response to different antigens in the infected mouse.

Authors:  C Ramos; E Lamoyi; M Feoli; M Rodriguez; M Perez; L Ortiz-Ortiz
Journal:  Exp Parasitol       Date:  1978-08       Impact factor: 2.011

7.  Immunoglobulin studies in serum of patients with American trypanosomiasis (Chagas' disease).

Authors:  R Lelchuk; A P Dalmasso; C L Inglesini; M Alvarez; J A Cerisola
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

8.  Studies of cellular immunity in Chagas disease: effect of glutaraldehyde-treated specific antigen on inhibition of leukocyte migration.

Authors:  R Lelchuk; A Patrucco; J A Manni
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

9.  The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi.

Authors:  F Kierszenbaum; L E Saavedra
Journal:  J Protozool       Date:  1972-11

10.  Suppression of cell-mediated immunity in experimental Chagas' disease.

Authors:  S G Reed; C L Larson; C A Speer
Journal:  Z Parasitenkd       Date:  1977-06-03
View more
  17 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Low-Level Parasite Persistence Drives Vasculitis and Myositis in Skeletal Muscle of Mice Chronically Infected with Trypanosoma cruzi.

Authors:  Joseph D Weaver; Victoria J Hoffman; Ester Roffe; Philip M Murphy
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.

Authors:  F Kierszenbaum
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

4.  Alterations in production of immunoglobulin classes and subclasses during experimental Trypanosoma cruzi infection.

Authors:  G K Jeng; F Kierszenbaum
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism.

Authors:  M B Soares; K N Silva-Mota; R S Lima; M C Bellintani; L Pontes-de-Carvalho; R Ribeiro-dos-Santos
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.

Authors:  L A Beltz; F Kierszenbaum; M B Sztein
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.

Authors:  F Kierszenbaum; H M Lopez; M B Sztein
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

8.  Binding of the specific ligand to Fc receptors on Trypanosoma cruzi increases the infective capacity of the parasite.

Authors:  C Rodriguez de Cuna; F Kierszenbaum; J J Wirth
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

9.  VNI cures acute and chronic experimental Chagas disease.

Authors:  Fernando Villalta; Mark C Dobish; Pius N Nde; Yulia Y Kleshchenko; Tatiana Y Hargrove; Candice A Johnson; Michael R Waterman; Jeffrey N Johnston; Galina I Lepesheva
Journal:  J Infect Dis       Date:  2013-01-31       Impact factor: 5.226

10.  Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide.

Authors:  Z A Andrade; S G Andrade; M Sadigursky
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.